Elevated serum YKL-40 levels in patients with Kawasaki disease

Biomarkers. 2017 May-Jun;22(3-4):326-330. doi: 10.1080/1354750X.2016.1265000. Epub 2016 Dec 9.

Abstract

Context: YKL-40 is an inflammatory biomarker for endothelial dysfunction that may have a role in Kawasaki disease (KD).

Objectives: We investigated the association of serum YKL-40 levels with KD and established laboratory parameters for YKL-40 levels and other inflammatory markers.

Methods: YKL-40 levels and other inflammatory markers of 23 KD patients, 9 disease control patients and 11 age-matched healthy controls.

Results: YKL-40 concentration in the serum of KD patients significantly increased during the acute disease phase compared with those of disease controls and healthy controls.

Conclusions: Increased YKL-40 levels may provide a useful inflammatory marker for patients with KD.

Keywords: Kawasaki disease; YKL-40; acute phase reactant.

MeSH terms

  • Acute Disease
  • Biomarkers / blood
  • Case-Control Studies
  • Chitinase-3-Like Protein 1 / blood*
  • Humans
  • Inflammation / blood
  • Mucocutaneous Lymph Node Syndrome / blood
  • Mucocutaneous Lymph Node Syndrome / pathology*

Substances

  • Biomarkers
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1